chr10-122461714-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_002775.5(HTRA1):c.62C>T(p.Ser21Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,294,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002775.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HTRA1 | NM_002775.5 | c.62C>T | p.Ser21Leu | missense_variant | 1/9 | ENST00000368984.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HTRA1 | ENST00000368984.8 | c.62C>T | p.Ser21Leu | missense_variant | 1/9 | 1 | NM_002775.5 | P1 | |
HTRA1 | ENST00000648167.1 | c.154+3005C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00000676 AC: 1AN: 147894Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000422 AC: 3AN: 71008Hom.: 0 AF XY: 0.0000490 AC XY: 2AN XY: 40786
GnomAD4 exome AF: 0.0000131 AC: 15AN: 1146560Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 7AN XY: 564418
GnomAD4 genome AF: 0.00000676 AC: 1AN: 148002Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 72110
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.62C>T (p.S21L) alteration is located in exon 1 (coding exon 1) of the HTRA1 gene. This alteration results from a C to T substitution at nucleotide position 62, causing the serine (S) at amino acid position 21 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at